Beilstein J. Org. Chem. 2014, 10, 1159–1165.
3. Hua, D. H.; Huang, X.; Tamura, M.; Chen, Y.; Woltkamp, M.; Jin, L.-W.;
Perchellet, E. M.; Perchellet, J.-P.; Chiang, P. K.; Namatame, I.;
Tomoda, H. Tetrahedron 2003, 59, 4795–4803.
tical method for the synthesis of functionalized 2-pyronyl ethers
which should find use in the synthesis of natural products and
other bioactive compounds.
4. Perchellet, E. M.; Ladesich, J. B.; Chen, Y.; Sin, H.-S.; Hua, D. H.;
Kraft, S. L.; Perchellet, J.-P. Anti-Cancer Drugs 1998, 9, 565–576.
Experimental
General procedure 1: Mitsunobu reaction with 4-hydroxy-2-
pyrones: To a stirred solution of the pyrone (1 equiv), tri-
phenylphosphine (1.5 equiv) and alcohol (1.5 equiv), in
dichloromethane (4 mL mmol−1) under nitrogen either at 0 °C
or ambient temperature, was carefully added DIAD (1.5 equiv)
over 10–30 min (depending on scale), so as to avoid the genera-
tion of excess heat (<5 °C internal temperature increase). The
solution was then stirred at rt (typically 18–25 ºC) for 16 hours,
and the solvent removed in vacuo. Byproduct phosphine oxide
was removed from the crude residue by dissolving the product
in ether (2 mL mmol−1), and vacuum filtration to remove the
solid oxide. The ether was then removed in vacuo and the
residue purified via flash column chromatography to afford the
desired product.
5. Shin, J.; Paul, V. J.; Fenical, W. Tetrahedron Lett. 1986, 27,
6. Mayer, A. M. S.; Paul, V. J.; Fenical, W.; Norris, J. N.;
de Carvalho, M. S.; Jacobs, R. S. Hydrobiologia 1993, 260–261,
7. Goel, A.; Ram, V. J. Tetrahedron 2009, 65, 7865–7913.
8. Burns, M. J. Towards the total synthesis of phacelocarpus 2-pyrone a:
Novel 2-pyrone chemistry. Ph.D. Thesis, University of York, York, U.K.,
2010.
9. Hansen, C. A.; Frost, J. W. J. Am. Chem. Soc. 2002, 124, 5926–5927.
10.Shimo, T.; Yasuda, M.; Tajima, J.; Somekawa, K. J. Heterocycl. Chem.
11.Zehnder, L. R.; Dahl, J. W.; Hsung, R. P. Tetrahedron Lett. 2000, 41,
12.Swamy, K. C. K.; Kumar, N. N. B.; Balaraman, E.; Kumar, K. V. P. P.
13.Ang, K.-P.; Tan, S.-F. J. Chem. Soc., Perkin Trans. 2 1979,
General procedure 2: Oxa-Michael addition with
4-hydroxy-2-pyrones: The pyrone (1 equiv), triethylamine
(1 equiv) and propiolate ester (2 equiv) were stirred in CH2Cl2
(2 mL mmol−1) at 45 °C for 16 h. The solvent was then
removed in vacuo and the product purified via flash column
chromatography to afford the desired product.
14.Burns, M. J.; Thatcher, R. J.; Taylor, R. J. K.; Fairlamb, I. J. S.
15.Moreno-Mañas, M.; Prat, M.; Ribas, J.; Virgili, A. Tetrahedron Lett.
16.Moreno-Mañas, M.; Ribas, J.; Virgili, A. J. Org. Chem. 1988, 53,
Supporting Information
17.Suzuki, E.; Katsuragawa, B.; Inoue, S. J. Chem. Res., Synop. 1979,
110–111.
Supporting Information File 1
18.Zhang, X.; McLaughlin, M.; Muñoz, R. L. P.; Hsung, R. P.; Wang, J.;
19.Nising, C. F.; Bräse, S. Chem. Soc. Rev. 2012, 41, 988–999.
Detailed experimental procedures, characterisation data for
compounds 3b–e, 4a–l, 5d, 7a–i and 9 and 1H NMR
spectra for novel compounds.
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
Acknowledgements
T.O.R. is funded by an EPSRC DTA PhD studentship. We are
grateful to Merck-Schering for CASE top-up funding (Drs.
Zoran Rankovic and Mark York). EPSRC grant EP/D078776/1
(PhD studentship for M.J.B.) part-funded this research. I.J.S.F.
thanks the Royal Society for previous support (University
Research Fellow).
permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic
Chemistry terms and conditions:
References
1. Fairlamb, I. J. S.; Marrison, L. R.; Dickinson, J. M.; Lu, F.-J.;
Schmidt, J. P. Bioorg. Med. Chem. 2004, 12, 4285–4299.
The definitive version of this article is the electronic one
which can be found at:
2. McGlacken, G. P.; Fairlamb, I. J. S. Nat. Prod. Rep. 2005, 22,
1165